Topic: Biology
Researchers discovered a way to stop cancer cells from repairing damaged DNA. This could help make cancer treatments more effective.
Cancer cells are very good at surviving treatments that damage their DNA. One reason is that they have special systems for fixing genetic damage. These systems can be exploited by certain cancer drugs, but many cancers adapt and become resistant to treatment. Now, scientists have found a way to overcome this resistance.
The team, led by Director Kyungjae Myung at the Institute for Basic Science (IBS), discovered that they could disrupt the machinery used by cancer cells to repair DNA. They did this by targeting proteins inside the cell that help with DNA repair. When these proteins were removed or reduced, the cancer cells struggled to fix damaged DNA.
The researchers identified a small molecule called UNI418 that can do this. When cancer cells are exposed to UNI418, levels of critical DNA repair proteins drop significantly. Without enough of these proteins, the cells cannot properly repair damaged DNA.
This finding could be especially important for overcoming resistance to PARP inhibitors, which is a major challenge in cancer treatment.
Why It Matters
This discovery could help make cancer treatments more effective and give patients better chances of recovery. It also highlights the importance of continued research into new ways to combat cancer's defenses.
Key Facts
- Cancer cells can survive DNA-damaging treatments by repairing genetic damage through homologous recombination.
- PARP inhibitors were designed to exploit weaknesses in DNA repair, but many cancers adapt and become resistant to treatment.
- Researchers identified a small molecule called UNI418 that disrupts the machinery used by cancer cells to repair DNA.
- UNI418 reduces levels of critical DNA repair proteins, making it harder for cancer cells to fix damaged DNA.
- This finding could help overcome resistance to PARP inhibitors and make cancer treatments more effective.
Key Terms
- Homologous recombination
- A highly accurate DNA repair process that depends on proteins like RAD51 and CHK1.
Implications
This discovery could help make cancer treatments more effective and give patients better chances of recovery. It also highlights the importance of continued research into new ways to combat cancer's defenses.
Source: https://www.sciencedaily.com/releases/2026/06/260610003052.htm
Journal Reference:
- Seon-gyeong Lee, Yuri Seo, Seula Jeong, Yuheon Chung, Sukyeong Kong, Minyoung Kim, Joon Ho Rhlee, Sihyeon Um, Bijoy P. Mathew, Saikat Maiti, Malleswara Rao Kuram, Mohamed Ahmed Abozeid, Areum Park, Ji-Na Yoo, Keon Woo Khim, Kyuwon Son, Enkhzul Amarsanaa, Kyunghan Kim, Sehoon Hong, Jiyeon Choi, In Bae Park, Eun A. Lee, Ji Hwan Jeon, Jun Hong Park, Joo Seok Han, Chan Young Park, Seyun Kim, Jang Hyun Choi, Sung You Hong, Min-Duk Seo, Hyuk Lee, Joo-Yong Lee, Kyungjae Myung. Targeting IP6 signaling to destabilize homologous recombination proteins to overcome PARP inhibitor resistance. Nature Communications, 2026; 17 (1) DOI: 10.1038/s41467-026-71421-z
Leave a Comment